This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Dec;22(12):660.

doi: 10.1038/s41568-022-00517-7.

Tumour avatars to model patients' responses to immunotherapy

Daniela S Thommen¹

Affiliations

PMID: 36167841
DOI: 10.1038/s41568-022-00517-7

Comment

Tumour avatars to model patients' responses to immunotherapy

Daniela S Thommen. Nat Rev Cancer. 2022 Dec.

. 2022 Dec;22(12):660.

doi: 10.1038/s41568-022-00517-7.

Author

Daniela S Thommen¹

Affiliation

¹ Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. d.thommen@nki.nl.

PMID: 36167841
DOI: 10.1038/s41568-022-00517-7

No abstract available

PubMed Disclaimer

Comment on

An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer.
Voabil P, de Bruijn M, Roelofsen LM, Hendriks SH, Brokamp S, van den Braber M, Broeks A, Sanders J, Herzig P, Zippelius A, Blank CU, Hartemink KJ, Monkhorst K, Haanen JBAG, Schumacher TN, Thommen DS. Voabil P, et al. Nat Med. 2021 Jul;27(7):1250-1261. doi: 10.1038/s41591-021-01398-3. Epub 2021 Jul 8. Nat Med. 2021. PMID: 34239134

References

Original article

1. Voabil, P. et al. An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer. Nat. Med. 27, 1250–1261 (2021) - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information